CF10 Displayed Improved Activity Relative to 5-FU in a Mouse CRLM Model Under Conditions of Physiological Folate

Charles Chidi Okechukwu(Wake Forest University), William H. Gmeiner(Wake Forest University)

Cancers

August 23, 2025

10.3390/cancers17172739

Cited by 2

Related Papers

CF10/LV overcomes acquired resistance to 5-FU/LV in colorectal cancer cells through downregulation of the c-Myc/ABCB5 axis

|Cancer Drug Resistance|2025|2

The fluoropyrimidine polymer CF10 synergizes with 5-ethynyl-2′-deoxyuridine by promoting telomere attrition and mitotic catastrophe

|NAR Molecular Medicine|2026|0

CF10 Displays Improved Synergy with Oxaliplatin in TP53-Null and Wild-Type CRC Cells from Increased Top1cc and Replication Stress

|Cancers|2026|0